Concepedia

Masaki Shibayama

MS

Statistics

Publications

9

Citations

815

H-Index

9

Active since

2002

Affiliations

Sysmex (Japan)(Current)

Leiden University Medical Center

The University of Osaka

The University of Tokyo

Kyoto University

Masaki Shibayama is an author at Sysmex (Japan) specializing in oncology, life sciences, and medicine.

Publications per year

2002–2013

9

Publications

9

FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis

Norihiko Ohbayashi, Masaki Shibayama, Yoko Kurotaki et al. · Genes & Development · 2002 · 480 citations · Full text

Medicine, Developmental Biology, Molecular Genetics +17

Fgf18 is required for embryonic lung alveolar development

Hiroko Usui, Masaki Shibayama, Norihiko Ohbayashi et al. · Biochemical and Biophysical Research Communications · 2004 · 89 citations

Life Sciences, Cell Biology, Developmental Biology +10

Polypyrimidine tract‐binding protein is essential for early mouse development and embryonic stem cell proliferation

Masaki Shibayama, Satona Ohno, Takashi Osaka et al. · FEBS Journal · 2009 · 88 citations · Full text

Life Sciences, Developmental Biology, Molecular Biology +15

Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer

Eliane C.M. Zeestraten, Matthias Maak, Masaki Shibayama et al. · British Journal of Cancer · 2011 · 48 citations · Full text

Medicine, Cancer Biology, Oncology +17

Recurrence risk score based on the specific activity of CDK1 and CDK2 predicts response to neoadjuvant paclitaxel followed by 5-fluorouracil, epirubicin and cyclophosphamide in breast cancers

S.J. Kim, Satoshi Nakayama, Kenzo Shimazu et al. · Annals of Oncology · 2011 · 26 citations · Full text

Medicine, Oncology, Pharmacology +14

1–5 of 9